Civil Society Involvement in Drug Policy


The objective of the assessment is to gain better insight and create a better understanding of the nature and extent of CSI in regard of drug policy in European Member States.

The assessment of civil society involvement in drug policy is currently being conducted in all Member States of the European Union. This includes a stakeholder and situation analysis, desk research, identification of good practice examples, standardized written interviews and expert interviews.

The assessment will cover the following:

  • Definitions and meaning of CSI
  • Local, national and European experiences and approaches regarding CSI
  • Impact and limitation analysis
  • Good practice examples of effective CSI (eg. for initiating new services, for implementing activities, for impact evaluation, etc.)
  • Conclusions
  • Recommendations, which can support the development of the roadmap and the national action plans.

The results are expected in 2017, will provide the basis for the development of a roadmap  for CSI in drug policy. The final report is expected at the beginning of 2018 and will be presented at the CSI conference  in 2018.


The Regenboog Group (RG) is the main applicant of the project.

RG is an Amsterdam-based NGO committed to people with social problems, such as homelessness, drug and alcohol use and psychiatric disorders. RG is the host of Correlation – European Network Social Inclusion & Health.

The Centre for Interdisciplinary Addiction Research of the Hamburg University (ZIS)

has a sound record of successfully implemented projects on national, European and international level.
The ZIS conducts practice-oriented research in the field of drug policy, drug treatment, harm reduction, monitoring and health promotion for a variety of vulnerable groups such as prisoners, sex workers, women, ageing drug users. It also organises conferences, capacity building seminars and provides education to health professionals.

Apdes (Portugal), Ana Liffey (Ireland), Droghe Forum (Italy), Lila (Italy), Initiative of Health (Bulgaria)

are all leading CSOs in their country, working with marginalized groups and people and engaging in political dialogue.

  • Ana Liffey also provides the chair of the civil society working group in the current CSF on Drugs.
  • Lila provided the co-chair of the Civil society Forum on HIV/AIDS.


is a research institute in Slovenia, engaged in national and European projects, also chairing the working group on quality standards at the Civil society Forum on Drugs.

A number of relevant European Networks support the activities:

  • European Civil Society Forum on Drugs
  • European Civil Society Forum on HIV/AIDS
  • International Drug Policy Consortium
  • Harm Reduction International (European Harm Reduction Network),
  • European Network of People Who Use Drugs
  • European AIDS Treatment Group


3 + 8 =

Your contact information will only be stored for the purpose of sending information on the conference. Your personal data can be deleted at any time upon request.


Civil Society Involvement in Drug Policy (CSIDP)
c/o Foundation De REGENBOOG GROEP
tel. +31 20 570 7826 (direct)
Droogbak 1d
1013 GE Amsterdam
The Netherlands


 Co-funded by the European Union